Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucovance in children with type 2 diabetes
NCT00035542Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2001
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glibenclamide + metformin in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Dec 2001; status: completed.
02
Drugs
glibenclamide + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00035542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035542.